'Cell knife' for cancer: the clinician's perspective.
Clicks: 2
ID: 281549
2025
Boron Neutron Capture Therapy (BNCT), often referred to as the 'cell knife,' represents a binary, tumor-selective therapeutic modality that minimizes damage to surrounding healthy tissues. This review provides a comprehensive clinical perspective on BNCT, addressing the radiobiological mechanisms and summarizing related clinical trials, with a particular emphasis on glioma and head and neck cancers. Furthermore, the paper touches upon the synergistic potential of BNCT when integrated with other treatment modalities, such as proton and carbon ion radiotherapy, alternative neutron capture therapies, ultrasound, and immunotherapy. These combined approaches may offer promising avenues for future research, potentially enhancing the therapeutic index and expanding the applicability of BNCT in oncological practice.
| Reference Key |
zhou2025cell
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Zhou, Zihan; Chen, Yunhao; Wang, Yao; Hong, Yafang; Guan, Hongdan; Huang, Fenghao; Fu, Fenfang; Li, Xiaobo; Zheng, Rong; Xu, Benhua |
| Journal | Frontiers in immunology |
| Year | 2025 |
| DOI | 10.3389/fimmu.2025.1536355 |
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.